Keiko Akahane

Papers

Total Citations

H-Index

About

Dr. Keiko Akahane is a distinguished urologic oncologist whose research focuses on improving outcomes for prostate cancer patients, particularly through the refinement of post-surgical treatment strategies. Her work centers on identifying predictive factors for prostate-specific antigen (PSA) recurrence following radical prostatectomy, with a specific emphasis on the role of histopathological patterns in guiding salvage radiotherapy. In her highly cited 2024 study, Dr. Akahane demonstrated that the cribriform pattern is a significant predictive factor for PSA recurrence in patients receiving radiotherapy after prostatectomy, offering clinicians a valuable tool for risk stratification and treatment planning. This contribution addresses a critical clinical challenge, as PSA recurrence after robotic total prostatectomy remains a persistent concern despite the procedure's popularity. By linking specific tumor morphology to treatment outcomes, her research helps optimize salvage radiotherapy protocols and potentially reduces recurrence rates. Dr. Akahane's work bridges the gap between pathology and radiation oncology, providing actionable insights that directly impact patient care. Her findings have been recognized as pivotal in the ongoing effort to personalize prostate cancer management, making her a key voice in the field of urologic oncology.